Drug Trial Radar · NCT07777835
Magnesium Sulphate With Atropine and Pralidoxime vs Standard Therapy Alone in Acute Organophosphate Poisoning
Last checked: Nov 19, 2026Latest source record: Aug 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
38
Planned (sponsor's estimate)
Start
May 10, 2026
Primary completion
Oct 10, 2026
Study completion Oct 10, 2026
Sponsor
- Lead sponsor
- Muhammad Aamir LatifAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 20, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Pakistan, being a developing country, is one of the regions with the most cases of organophosphate (OP) poisoning/toxicity. MgSO4 is one of the most promising adjunctive treatments that needs to be tested. This study is being carried out with the objective of comparing the 15-day all-cause mortality rate and the total cumulative atropine requirement during hospitalization between patients receiving adjunctive magnesium sulphate with standard therapy and those receiving standard therapy alone.
Conditions
- Organophosphate Poisoning
Interventions
Atropine plus pralidoximeDrug
Patients will be treated with standard atropine and pralidoxime therapy along with adjunctive MgSO4 (loading dose of 4g in 100ml N/S intravenous infusion over 30 minutes, followed by 1g/hr in 100ml N/S continuous IV infusion for 24 hours).
Atropine and pralidoxime with adjunctive MgSO4Drug
Patients will be treated with standard atropine plus pralidoxime therapy alone.
Primary outcomes
What the sponsor says the trial is designed to measure.
- MortalityTime frame: 15 days after hospital admission
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nishtar Hospital/Medical University
Multan, Punjab Province, Pakistan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.